Clinical Trial Update: Evaluation of Memantine in the Preservation of Memory and Neurocognition Following CSI [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating memantine for the preservation of memory and neurocognition after craniospinal irradiation; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurocognitive Disorders

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Tata Memorial Centre | Conditions: Neurocognitive Dysfunction | Phase 3 | Status: RECRUITING